DNA microarray analysis of neonatal mouse lung connects regulation of KDR with dexamethasone-induced inhibition of alveolar formation

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 286, Issue 2 30-2, 2004, Pages

  Clerch, Linda Biadasz ^a   Baras, Alex S ^a   DeCarlo Massaro, Gloria ^a   Hoffman, Eric P ^b   Massaro, Donald ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Corticosteroid; Kinase domain receptor; Lung development; Retinoic acid

Indexed keywords

DEXAMETHASONE; RETINOIC ACID; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL COMMUNICATION AND CELL CONTACT; CELL GROWTH; COMPUTER PROGRAM; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; INHIBITION KINETICS; LUNG ALVEOLUS; LUNG DEVELOPMENT; MOLECULAR BIOLOGY; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; RNA ISOLATION; SIGNAL TRANSDUCTION;

EID: 1642541275     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00306.2003     Document Type: Article

References (42)

1. American Academy of Pediatrics, Committee on Fetus, and Newborn and Canadian Pediatric Society, Fetus and Newborn Committee. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 109: 330-338, 2002.
2. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, and Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29, 2000.
3. Balasubramaniam V, Tang JR, Maxey A, Plopper CG, and Abman SH. Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse. Am J Physiol Lung Cell Mol Physiol 284: L954-L971, 2003.
4. Bhatt AJ, Amin SB, Chess PR, Watkins RH, and Maniscalco WM. Expression of vascular endothelial growth factor and Flk-1 in developing and glucocorticoid-treated mouse lung. Pediatr Res 47: 606-613, 2000.
5. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, and Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and Tie-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 164: 1971-1980, 2001.
6. Blanco LN, Massaro GD, and Massaro D. Alveolar dimensions and number: developmental and hormonal regulation. Am J Physiol Lung Cell Mol Physiol 257: L240-L247, 1989.
7. Box GEP, Hunter WG, and Hunter JS. Statistics for Experimenters. New York: Wiley, 1978.
8. Brown KRS, England KM, Goss KL, Synder JM, and Acarregui MJ. VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. Am J Physiol Lung Cell Mol Physiol 281: L1001-L1010, 2001.
9. Burri PH. The postnatal growth of the rat lung. III, Morphology. Anat Rec 180: 77-98, 1974.
10. Burri PH, Dbaly J, and Weibel ER. The postnatal growth of the rat lung. I. Morphometry. Anat Rec 178: 711-730, 1974.
11. Chen J, Zhao P, Massaro D, Clerch LB, Almon RR, DuBois DC, Jusko WJ, and Hoffman EP. The PEPR GeneChip data warehouse and implementation of a dynamic time series query tool (SGQT) with graphical interface. Nucleic Acids Res. In press.
12. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Kesher I, Lupu F, Nemery B, Dewerchin M, Van Veldhoven P, Plate K, Moons L, Collen D, and Carmeliet P. Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8: 702-710, 2002.
13. Cruz-Orive LM and Weibel ER. Sampling designs for stereology. J Microsc 122: 235-257, 1981.
14. Ferrara N, Gerber HP, and Le Couter J. The biology of VEGF and its receptors. Nat Med 9: 669-676, 2003.
15. Hosford GE and Olson DM. Effects of hyperoxia on VEGF, its receptors, and HIF-2α in the newborn rat lung. Am J Physiol Lung Cell Mol Physiol 285: L161-L168, 2003.
16. Husain AN, Siddiqui NH, and Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 29: 710-717, 1998.
17. Jacobs HC, Chapman RL, and Gross I. Premature conclusions on postnatal steroid effects. Pediatrics 110: 200-201, 2002.
18. Jakkula M, LeCras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, and Abman SH. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 279: L600-L607, 2000.
19. Langston C, Kida K, Reed M, and Thurlbeck WM. Human lung growth in late gestation and in the neonate. Am Rev Respir Dis 129: 607-613, 1984.
20. Leco KJ, Waterhouse P, Sanchez OH, Gowing KLM, Poole AR, Wakeham A, Mak TW, and Khokha R. Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest 108: 817-829, 2001.
21. LeCras TD, Markhan NE, Tuder RM, Voelkel NF, and Abman SH. Treatment of newborn rats with VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol 283: L555-L562, 2002.
22. Liu G, Loraine AE, Shigeta R, Cline M, Cheng J, Valmeekam V, Sun S, Kulp D, and Siani-Rose MA. NetAffx: Affymetrix probe sets and annotations. Nucleic Acids Res 31: 82-86, 2003.
23. Maden M and Hind M. Retinoic acid, a regeneration-inducing molecule. Dev Dyn 226: 237-244, 2003.
24. Manji JS, O'Kelly CJ, Leung WI, and Olson DM. Timing of hyperoxic exposure during alveolarization influences damage mediated by leukotrienes. Am J Physiol Lung Cell Mol Physiol 281: L799-L806, 2001.
25. Massaro D, Teich N, Maxwell S, Massaro GD, and Whitney P. Postnatal development of alveoli: regulation and evidence for a critical period. J Clin Invest 76: 1297-1305, 1985.
26. Massaro GD and Massaro D. Formation of alveoli in rats: postnatal effect of prenatal dexamethasone. Am J Physiol Lung Cell Mol Physiol 263: L37-L41, 1992.
27. Massaro GD and Massaro D. Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats. Am J Physiol Lung Cell Mol Physiol 270: L305-L310, 1996.
28. Massaro GD and Massaro D. Retinoic acid treatment partially rescues failed septation in rats and mice. Am J Physiol Lung Cell Mol Physiol 278: L955-L960, 2000.
29. 2 and a critical period. Am J Physiol Lung Cell Mol Physiol 258: L321-L327, 1990.
30. Massaro GD, Radaeva S, Clerch LB, and Massaro D. Lung alveoli: endogenous programmed destruction and regeneration. Am J Physiol Lung Cell Mol Physiol 283: L305-L309, 2002.
31. Millauer B, Wizigmann-Voos S, Schnurch J, Martinez R, Moller NPH, Risau W, and Ulirich A. High affinity VEGF binding and development expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 772: 835-846, 1993.
32. Milliken GA and Johnson DE. Analysis of Messy Data, Volume 1: Designed Experiments. Belmont, CA: Wadsworth, 1984.
33. Neufeld G, Cohen T, Gengrinovitch S, and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9-22, 1999.
34. Perlman J. American Academy of Pediatrics. Fetus and Newborn Committee Concern about fetus and Newborn Committee statement of corticosteroid use. Pediatrics 110: 1034, 2002.
35. Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, Bond M, Baker A, and Anand-Apte B. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP-3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 9: 407-415, 2003.
36. Sahebjami H and Domino M. Effects of postnatal dexamethasone treatment on development of alveoli in adult rats. Exp Lung Res 15: 961-973, 1989.
37. Satterthwaite FE. An approximate distribution of estimates of variance components. Biometrics Bulletin 2: 110-114, 1946.
38. Scherle W. A simple method for volumetry organs in quantitative stereology. Mikroskopie 26: 57-60, 1970.
39. Taylor C, Shah PS, and Dunn MS. Meta-analysis of postnatal steroid use challenged. Pediatrics 109: 716-717, 2002.
40. Vaucher YE. Bronchopulmonary dysplasia: an enduring challenge. Pediatr Rev 23: 349-357, 2002.
41. Zeltner TB and Burri PH. The postnatal development and growth of the human lung. II. Morphology. Respir Physiol 67: 269-282, 1987.
42. Zeltner TB, Caduff JH, Gehr P, Pfenninger J, and Burri PH. The postnatal development and growth of the human lung. I. Morphology. Respir Physiol 67: 247-267, 1987.